Pitt Innovators Deliver Robust Year of Impact in Fiscal 2026
Fiscal Year 2026 marked a year of remarkable progress across the University of Pittsburgh’s... Read more
Renerva’s main focus is to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures. The company is committed to developing the next generation of surgical solutions to improve peripheral nerve repair, accelerate healing following a nerve injury, and improve nerve function following injury and repair.